Sign in

Filings

Finds words inside filing documents. Searching Akebia Therapeutics, Inc.'s filings · 40 documents indexed.

18 documents · 101 matches

  1. AKBA Akebia Therapeutics, Inc. 10-Q 2026-05-07

    Item 1A. Risk Factors.

    tariffs, invalidating both the reciprocal tariffs and the drug trafficking tariffs. Shortly thereafter, President Trump issued a new Executive Order
    16 matches in this document

  2. AKBA Akebia Therapeutics, Inc. 10-Q 2026-08-05

    Item 1A. Risk Factors.

    tariff, which could be raised to 15%, on nearly all foreign imports, or the Section 122 tariffs. The Section 122 tariffs
    13 matches in this document

  3. AKBA Akebia Therapeutics, Inc. 10-K 2026-02-26

    Item 1A. Risk Factors.

    tariff of 10% on all U.S. trading partners effective April 5, 2025, and higher individualized reciprocal tariffs on 57 countries
    13 matches in this document

  4. AKBA Akebia Therapeutics, Inc. 10-Q 2025-11-10

    Item 1A. Risk Factors.

    tariff of 10% on all U.S. trading partners effective April 5, 2025, and higher individualized reciprocal tariffs on 57 countries
    12 matches in this document

  5. AKBA Akebia Therapeutics, Inc. 10-Q 2025-08-07

    Item 1A. Risk Factors.

    tariff-related actions against U.S. trading partners. In February 2025, the Trump Administration imposed a 25% tariff on Canada and Mexico
    10 matches in this document

  6. AKBA Akebia Therapeutics, Inc. 10-Q 2025-05-08

    Item 1A. Risk Factors.

    tariffs on U.S. trading partners. On April 2, 2025, the President issued an Executive Order announcing a “baseline” reciprocal tariff
    11 matches in this document

  7. AKBA Akebia Therapeutics, Inc. 10-Q 2026-11-05

    Item 1A. Risk Factors.

    tariffs, invalidating both the “reciprocal” tariffs and certain country-specific tariffs previously imposed by executive orders. Following this decision, the U.S. Customs
    15 matches in this document

  8. AKBA Akebia Therapeutics, Inc. 8-K 2026-11-05

    termination of any of Akebia's collaborations; and changes in the geopolitical environment and uncertainty surrounding U.S. trade policy on tariffs.
    1 match in this document

  9. AKBA Akebia Therapeutics, Inc. 8-K 2026-08-05

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's most recent Quarterly Report
    1 match in this document

  10. AKBA Akebia Therapeutics, Inc. 8-K 2026-06-30

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's most recent Quarterly Report
    1 match in this document

  11. AKBA Akebia Therapeutics, Inc. 8-K 2026-05-07

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's Report on Form 10-K for the year
    1 match in this document

  12. AKBA Akebia Therapeutics, Inc. 8-K 2026-02-26

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's Quarterly Report on Form
    1 match in this document

  13. AKBA Akebia Therapeutics, Inc. 8-K 2026-01-12

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's Quarterly Report on Form
    1 match in this document

  14. AKBA Akebia Therapeutics, Inc. 8-K 2026-01-12

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's Quarterly Report on Form
    1 match in this document

  15. AKBA Akebia Therapeutics, Inc. 8-K 2025-12-01

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's Quarterly Report on Form
    1 match in this document

  16. AKBA Akebia Therapeutics, Inc. 8-K 2025-11-10

    termination of any of Akebia's collaborations; and changes in the geopolitical environment and uncertainty surrounding U.S. trade policy on tariffs.
    1 match in this document

  17. AKBA Akebia Therapeutics, Inc. 8-K 2025-10-28

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's Quarterly Report on Form
    1 match in this document

  18. AKBA Akebia Therapeutics, Inc. 8-K 2025-08-07

    tariffs. Other risks and uncertainties include those identified under the heading "Risk Factors" in Akebia's Quarterly Report on Form
    1 match in this document

Page 1 of 1 · 18 documents